NeueHealth (NEUE) Competitors $6.56 -0.16 (-2.38%) Closing price 08/15/2025 03:59 PM EasternExtended Trading$6.59 +0.03 (+0.46%) As of 08/15/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEUE vs. KINS, GOCO, HIT, RDZN, FGF, AAME, ZBAO, HUIZ, AIFU, and OXBRShould you be buying NeueHealth stock or one of its competitors? The main competitors of NeueHealth include Kingstone Companies (KINS), GoHealth (GOCO), Health In Tech (HIT), Roadzen (RDZN), Fundamental Global (FGF), Atlantic American (AAME), Zhibao Technology (ZBAO), Huize (HUIZ), AIFU (AIFU), and Oxbridge Re (OXBR). These companies are all part of the "insurance" industry. NeueHealth vs. Its Competitors Kingstone Companies GoHealth Health In Tech Roadzen Fundamental Global Atlantic American Zhibao Technology Huize AIFU Oxbridge Re Kingstone Companies (NASDAQ:KINS) and NeueHealth (NYSE:NEUE) are both small-cap insurance companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Which has preferable valuation and earnings, KINS or NEUE? Kingstone Companies has higher earnings, but lower revenue than NeueHealth. NeueHealth is trading at a lower price-to-earnings ratio than Kingstone Companies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKingstone Companies$155.14M1.26$18.36M$2.006.99NeueHealth$936.66M0.06-$134.68M-$15.97-0.41 Which has more volatility and risk, KINS or NEUE? Kingstone Companies has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, NeueHealth has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Do analysts recommend KINS or NEUE? NeueHealth has a consensus target price of $7.00, indicating a potential upside of 6.71%. Given NeueHealth's stronger consensus rating and higher possible upside, analysts plainly believe NeueHealth is more favorable than Kingstone Companies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kingstone Companies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeueHealth 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders have more ownership in KINS or NEUE? 14.9% of Kingstone Companies shares are held by institutional investors. Comparatively, 63.9% of NeueHealth shares are held by institutional investors. 5.1% of Kingstone Companies shares are held by company insiders. Comparatively, 63.3% of NeueHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the media prefer KINS or NEUE? In the previous week, Kingstone Companies had 2 more articles in the media than NeueHealth. MarketBeat recorded 3 mentions for Kingstone Companies and 1 mentions for NeueHealth. Kingstone Companies' average media sentiment score of 0.70 beat NeueHealth's score of 0.51 indicating that Kingstone Companies is being referred to more favorably in the media. Company Overall Sentiment Kingstone Companies Positive NeueHealth Positive Is KINS or NEUE more profitable? Kingstone Companies has a net margin of 14.84% compared to NeueHealth's net margin of -9.08%. Kingstone Companies' return on equity of 36.24% beat NeueHealth's return on equity.Company Net Margins Return on Equity Return on Assets Kingstone Companies14.84% 36.24% 6.83% NeueHealth -9.08%N/A -13.01% SummaryKingstone Companies beats NeueHealth on 9 of the 15 factors compared between the two stocks. Get NeueHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for NEUE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEUE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEUE vs. The Competition Export to ExcelMetricNeueHealthMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$60.66M$7.55B$5.66B$20.94BDividend YieldN/A2.79%3.79%3.58%P/E Ratio-0.4173.3830.5827.94Price / Sales0.0630.99464.6655.86Price / CashN/A25.7937.4023.77Price / Book-0.0417.309.095.26Net Income-$134.68M$243.10M$3.25B$994.11M7 Day Performance-2.67%3.01%7.32%1.79%1 Month Performance-4.51%1.52%5.42%1.73%1 Year Performance29.64%18.72%30.66%13.35% NeueHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEUENeueHealth1.0939 of 5 stars$6.56-2.4%$7.00+6.7%+28.6%$60.66M$936.66M-0.411,252Short Interest ↑Gap DownKINSKingstone Companies2.9866 of 5 stars$15.76-0.5%N/A+52.3%$220.80M$155.14M9.9190Positive NewsGOCOGoHealth3.1012 of 5 stars$5.91+5.2%$18.00+204.6%-31.4%$140.30M$798.89M-4.922,261HITHealth In TechN/A$2.19-12.0%$2.50+14.2%N/A$119.73M$26.69M0.0079Positive NewsRDZNRoadzen2.1142 of 5 stars$1.17+5.4%$5.00+327.4%-29.1%$86.92M$44.30M-0.77324Earnings ReportShort Interest ↑Gap UpFGFFundamental Global2.3562 of 5 stars$37.99+0.4%N/A-12.7%$48.63M$17.35M29.009News CoverageGap DownHigh Trading VolumeAAMEAtlantic American1.7304 of 5 stars$2.36+0.2%N/A+98.7%$48.04M$188.23M-26.16140News CoverageEarnings ReportShort Interest ↓Gap UpZBAOZhibao TechnologyN/A$1.00flatN/A-70.3%$31.52M$25.27M0.00148Gap DownHUIZHuize1.3913 of 5 stars$2.35+7.8%$2.30-2.1%-89.2%$23.71M$171.10M-5.601,640Positive NewsShort Interest ↓AIFUAIFUN/A$6.86-2.3%N/AN/A$19.86M$1.81B9.404,707Positive NewsGap UpOXBROxbridge Re3.0167 of 5 stars$1.73-3.6%$5.00+189.0%-33.1%$12.87M$550K-5.773News CoverageEarnings ReportShort Interest ↓ Related Companies and Tools Related Companies Kingstone Companies Alternatives GoHealth Alternatives Health In Tech Alternatives Roadzen Alternatives Fundamental Global Alternatives Atlantic American Alternatives Zhibao Technology Alternatives Huize Alternatives AIFU Alternatives Oxbridge Re Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:NEUE) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeueHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeueHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access